Guidance on PFAS exposure, testing, and clinical follow-up

In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because...

Full description

Bibliographic Details
Corporate Authors: National Academies of Sciences, Engineering, and Medicine (U.S.) Committee on the Guidance on PFAS Testing and Health Outcomes, National Academies of Sciences, Engineering, and Medicine (U.S.) Board on Population Health and Public Health Practice, National Academies of Sciences, Engineering, and Medicine (U.S.) Board on Environmental Studies and Toxicology
Format: eBook
Language:English
Published: Washington, DC National Academies Press 2022, [2022]
Series:Consensus study report
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because they have properties that repel oil and water, reduce friction, and resist temperature changes. PFAS can leak into the environment where they are made, used, disposed of, or spilled. PFAS exposure has been linked to a number of adverse health effects including certain cancers, thyroid dysfunction, changes in cholesterol, and small reductions in birth weight. This report recommends that the Centers for Disease Control and Prevention (CDC) update its clinical guidance to advise clinicians to offer PFAS blood testing to patients who are likely to have a history of elevated exposure, such as those with occupational exposures or those who live in areas known to be contaminated. If testing reveals PFAS levels associated with an increased risk of adverse effects, patients should receive regular screenings and monitoring for these and other health impacts. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up recommends that the CDC, Agency for Toxic Substances and Disease Registry (ATSDR), and public health departments support clinicians by creating educational materials on PFAS exposure, potential health effects, the limitations of testing, and the benefits and harms of testing
Physical Description:1 PDF file (xx, 279 pages) illustrations
ISBN:9780309482448
0309482445